Grantham, Mayo, Van Otterloo & Co (GMO)’s Covisint Corporation COVS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio COVS Stock Details COVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-273,987	Closed	-$597K	–	620
2016 Q2	$597K	Sell	273,987 -141,924	-34%	-$275K	﹤0.01%	456
2016 Q1	$832K	Hold	415,911	–	–	﹤0.01%	429
2015 Q4	$1.04M	Hold	415,911	–	–	﹤0.01%	392
2015 Q3	$894K	Hold	415,911	–	–	﹤0.01%	413
2015 Q2	$1.36M	Hold	415,911	–	–	﹤0.01%	343
2015 Q1	$844K	Hold	415,911	–	–	﹤0.01%	373
2014 Q4	$1.1M	Buy	+415,911	New	+$1.19M	﹤0.01%	367

Other funds holding COVS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

DCM

Dialectic Capital Management Norwalk, Connecticut $155M AUM 59.34% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s COVS Position: Q3 2016 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Covisint Corporation (COVS) in Q3 2016, closing a stake of 273,987 shares — an estimated $597K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in COVS in Q4 2014 and held it in 7 quarters. The position peaked at $1.36M in Q2 2015. 59 funds tracked by Wall St. Rank hold COVS as of Q3 2016.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Covisint Corporation position as of Q3 2016 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 273,987 Covisint Corporation shares in Q3 2016, an estimated $597K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Covisint Corporation in Q4 2014 and held it in 7 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Covisint Corporation position peaked at $1.36M in Q2 2015.
59 funds tracked by Wall St. Rank held Covisint Corporation as of Q3 2016.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2016, filed 10 Nov 2016.